{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:05Z","timestamp":1790456045040,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002702","name":"Aalborg Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002702","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region Nordjyllands Sundhedsvidenskabelige Forskningsfond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Systemic inflammatory processes plausibly contribute to the development of cardiovascular complications, causing increased morbidity and mortality in type 2 diabetes. Circulating inflammatory markers, i.e., interleukin (IL)-6 and tumour necrosis factor-\u03b1, are associated with neurocardiac measures. We examined a broad panel of various inflammatory and inflammation-related serum markers to obtain more detailed insight into the possible neuro-immune interaction between cardiovascular regulation and systemic level of inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 100 participants with type 2 diabetes were analysed. Heart rate variability, cardiovascular autonomic reflex tests, and cardiac vagal tone tests were performed based on electrocardiographic readings. Data regarding covariates (demographic-, diabetes-, and cardiovascular risk factors) were registered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Increased serum levels of IL-12\/IL-23p40 (p\u2009 &lt;\u20090.01) and intercellular adhesion molecule (ICAM)-1 (p \u2009&lt;\u20090.007) were associated with diminished heart rate variability measures. After all adjustments, the associations between IL-12\/23p40, SDANN and VLF persisted (p\u2009 =\u20090.001). Additionally, serum levels of vascular endothelial growth factor (VEGF)-C were associated with response to standing (p\u2009 =\u20090.005).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The few but robust associations between neurocardiac regulation and serum markers found in this study suggest systemic changes in proinflammatory, endothelial, and lymphatic function, which collectively impacts the systemic cardiovascular function. Our results warrant further exploration of IL-12\/IL-23p40, ICAM-1, and VEGF-C as possible cardiovascular biomarkers in T2D that may support future decisions regarding treatment strategies for improved patient care.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12933-021-01437-w","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T15:02:40Z","timestamp":1641481360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Elevated levels of interleukin-12\/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8323-4843","authenticated-orcid":false,"given":"A. M.","family":"Wegeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Okdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ejskjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pociot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"St\u00f8rling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:1\u201319. https:\/\/doi.org\/10.1186\/s12933-018-0728-6.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jdi.12042","volume":"4","author":"AI Vinik","year":"2013","unstructured":"Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013;4:4\u201318.","journal-title":"J Diabetes Investig"},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285\u201393. https:\/\/doi.org\/10.2337\/dc10-1303.","journal-title":"Diabetes Care"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","volume":"17","author":"M Malik","year":"1996","unstructured":"Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ, et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354\u201381.","journal-title":"Eur Heart J"},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/157339906776818532","volume":"2","author":"J Greenfield","year":"2006","unstructured":"Greenfield J, Campbell L. Relationship between inflammation, insulin resistance and type 2 diabetes: cause or effect? Curr Diabetes Rev. 2006;2:195\u2013211.","journal-title":"Curr Diabetes Rev"},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14-31.","journal-title":"Diabetes Care"},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.5213\/inj.1632604.302","volume":"20","author":"H Hong","year":"2016","unstructured":"Hong H, Kim BS, Im HI. Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int Neurourol J. 2016;20:S2-7.","journal-title":"Int Neurourol J"},{"key":"1437_CR9","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2018.33.1","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol Rev. 2019. https:\/\/doi.org\/10.15420\/ecr.2018.33.1.","journal-title":"Eur Cardiol Rev"},{"key":"1437_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-019-00435-w","author":"P Bhati","year":"2019","unstructured":"Bhati P, Alam R, Moiz JA, Hussain ME. Subclinical inflammation and endothelial dysfunction are linked to cardiac autonomic neuropathy in type 2 diabetes. J Diabetes Metab Disord. 2019. https:\/\/doi.org\/10.1007\/s40200-019-00435-w.","journal-title":"J Diabetes Metab Disord"},{"key":"1437_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/878760","author":"DC Lieb","year":"2012","unstructured":"Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res. 2012. https:\/\/doi.org\/10.1155\/2012\/878760.","journal-title":"Exp Diabetes Res"},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0634-3","volume":"16","author":"CS Hansen","year":"2017","unstructured":"Hansen CS, Vistisen D, J\u00f8rgensen ME, Witte DR, Brunner EJ, Tab\u00e1k AG, et al. Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study. Cardiovasc Diabetol. 2017;16:1\u20139. https:\/\/doi.org\/10.1186\/s12933-017-0634-3.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1475-2840-11-24","volume":"11","author":"CH Jung","year":"2012","unstructured":"Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2012;11:24.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/heartjnl-2015-309181","volume":"103","author":"C Herder","year":"2017","unstructured":"Herder C, Schamarek I, Nowotny B, Carstensen-Kirberg M, Stra\u00dfburger K, Nowotny P, et al. Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes. Heart. 2017;103:63\u201370.","journal-title":"Heart"},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0953-6205(02)00014-6","volume":"13","author":"EB Jude","year":"2002","unstructured":"Jude EB, Douglas JT, Anderson SG, Young MJ, Boulton AJM. Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. Eur J Intern Med. 2002;13:185\u20139.","journal-title":"Eur J Intern Med"},{"key":"1437_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey KJ. The inflammatory reflex. Nature. 2002;420:853\u20139.","journal-title":"Nature"},{"key":"1437_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.psyneuen.2008.08.007","volume":"33","author":"A Haensel","year":"2008","unstructured":"Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology. 2008;33:1305\u201312.","journal-title":"Psychoneuroendocrinology"},{"key":"1437_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14261","author":"T Okdahl","year":"2020","unstructured":"Okdahl T, Brock C, Fl\u00f8yel T, Wegeberg A-ML, Jakobsen PE, Ejskjaer N, et al. Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes. Clin Endocrinol. 2020. https:\/\/doi.org\/10.1111\/cen.14261.","journal-title":"Clin Endocrinol"},{"key":"1437_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.600865","author":"MN Jarczok","year":"2021","unstructured":"Jarczok MN, Buckley T, Guendel HO, Boeckelmann I, Mauss D, Thayer JF, et al. 24 h-heart rate variability as a communication tool for a personalized psychosomatic consultation in occupational health. Front Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnins.2021.600865.","journal-title":"Front Neurosci"},{"key":"1437_CR20","doi-asserted-by":"publisher","first-page":"108517","DOI":"10.1016\/j.diabres.2020.108517","volume":"170","author":"AM Wegeberg","year":"2020","unstructured":"Wegeberg AM, Lunde ED, Riahi S, Ejskjaer N, Drewes AM, Brock B, et al. Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: aspects of utility in type 1 diabetes. Diabetes Res Clin Pract. 2020;170:108517. https:\/\/doi.org\/10.1016\/j.diabres.2020.108517.","journal-title":"Diabetes Res Clin Pract"},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.numecd.2010.07.005","volume":"21","author":"V Spallone","year":"2011","unstructured":"Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, et al. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21:69\u201378. https:\/\/doi.org\/10.1016\/j.numecd.2010.07.005.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1437_CR22","first-page":"362","volume":"27","author":"AD Farmer","year":"2014","unstructured":"Farmer AD, Coen SJ, Kano M, Weltens N, Ly HG, Botha C, et al. Normal values and reproducibility of the real-time index of vagal tone in healthy humans: a multi-center study. Ann Gastroenterol. 2014;27:362\u20138.","journal-title":"Ann Gastroenterol"},{"key":"1437_CR23","doi-asserted-by":"publisher","first-page":"e0182611","DOI":"10.1371\/journal.pone.0182611","volume":"12","author":"H Usui","year":"2017","unstructured":"Usui H, Nishida Y. The very low-frequency band of heart rate variability represents the slow recovery component after a mental stress task. PLoS ONE. 2017;12:e0182611. https:\/\/doi.org\/10.1371\/journal.pone.0182611.","journal-title":"PLoS ONE"},{"key":"1437_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-2-11","volume":"2","author":"EZ Fisman","year":"2003","unstructured":"Fisman EZ, Motro M, Tenenbaum A. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the loof. Cardiovasc Diabetol. 2003;2:1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdi.12794","volume":"9","author":"HY Jin","year":"2018","unstructured":"Jin HY, Park TS. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Investig. 2018;9:1016.","journal-title":"J Diabetes Investig"},{"key":"1437_CR26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/2472555220954389","volume":"25","author":"M Platchek","year":"2020","unstructured":"Platchek M, Lu Q, Tran H, Xie W. Comparative analysis of multiple immunoassays for cytokine profiling in drug discovery. SLAS Discov Adv life Sci R D. 2020;25:1197\u2013213.","journal-title":"SLAS Discov Adv life Sci R D"},{"key":"1437_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.10.010","author":"T van der Heijden","year":"2019","unstructured":"van der Heijden T, Bot I, Kuiper J. The IL-12 cytokine family in cardiovascular diseases. Cytokine. 2019. https:\/\/doi.org\/10.1016\/j.cyto.2017.10.010.","journal-title":"Cytokine"},{"key":"1437_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/ajh\/hps032","volume":"26","author":"K Young","year":"2013","unstructured":"Young K, Dogra G, Boudville N, Chan D, Adams L, Ching H, et al. Interleukin-12 is associated with arterial stiffness in healthy individuals. Am J Hypertens. 2013;26:159\u201362.","journal-title":"Am J Hypertens"},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cyto.2008.02.014","volume":"42","author":"M Wegner","year":"2008","unstructured":"Wegner M, Winiarska H, Bobkiewicz-Koz\u0142owska T, Dworacka M. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine. 2008;42:312\u20136.","journal-title":"Cytokine"},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.diabres.2011.07.037","volume":"94","author":"M Mishra","year":"2011","unstructured":"Mishra M, Kumar H, Bajpai S, Singh RK, Tripathi K. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2011;94:255\u201361.","journal-title":"Diabetes Res Clin Pract"},{"key":"1437_CR31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","volume":"30","author":"CP Domingueti","year":"2016","unstructured":"Domingueti CP, Dusse LMSA, Carvalho MDG, De Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat. 2016;30:738\u201345. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.12.018.","journal-title":"J Diabetes Complicat"},{"key":"1437_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1464-5491.2011.03546.x","volume":"29","author":"MN Pham","year":"2012","unstructured":"Pham MN, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, et al. Increased serum concentrations of adhesion molecules but not of chemokines in patients with type 2 diabetes compared with patients with type 1 diabetes and latent autoimmune diabetes in adult age: action LADA5. Diabet Med. 2012;29:470\u20138.","journal-title":"Diabet Med"},{"key":"1437_CR33","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1136\/heartjnl-2018-314461","volume":"105","author":"N Telinius","year":"2019","unstructured":"Telinius N, Hjortdal VE. Role of the lymphatic vasculature in cardiovascular medicine. Heart. 2019;105:1777\u201384.","journal-title":"Heart"},{"key":"1437_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01043-2","volume":"19","author":"YH Chan","year":"2020","unstructured":"Chan YH, Lee HF, Li PR, Liu JR, Chao TF, Wu LS, et al. Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants. Cardiovasc Diabetol. 2020;19:1\u201314. https:\/\/doi.org\/10.1186\/s12933-020-01043-2.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01238-1","author":"A Wang","year":"2021","unstructured":"Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, et al. Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021. https:\/\/doi.org\/10.1186\/s12933-021-01238-1.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01096-3","volume":"19","author":"WJ Tu","year":"2020","unstructured":"Tu WJ, Qiu HC, Liu YK, Liu Q, Zeng X, Zhao J. Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke. Cardiovasc Diabetol. 2020;19:1\u201313. https:\/\/doi.org\/10.1186\/s12933-020-01096-3.","journal-title":"Cardiovasc Diabetol"},{"key":"1437_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3590389","author":"AML Wegeberg","year":"2020","unstructured":"Wegeberg AML, Okdahl T, Fl\u00f8yel T, Brock C, Ejskjaer N, Riahi S, et al. Circulating inflammatory markers are inversely associated with heart rate variability measures in type 1 diabetes. Mediat Inflamm. 2020. https:\/\/doi.org\/10.1155\/2020\/3590389.","journal-title":"Mediat Inflamm"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-021-01437-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T04:24:51Z","timestamp":1674361491000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01437-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01437-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"24 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, local regulations, and the International Conference on Harmonization Good Clinical Practice guidelines. The North Denmark Region Committee on Health Research Ethics, Denmark (N-20170045) approved the protocol, amendments, and informed consent form. All subjects gave their informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests associated with this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}